Carlos Brotons Selected Research

2,5-dihydroxybenzene-1,4-disulfonic acid-bis(diethylamine) (263E)

8/2006

[Health economic evaluation of low-dose acetylsalicylic acid in the primary prevention of cardiovascular disease].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos Brotons Research Topics

Disease

9	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 08/2003
7	Hypertension (High Blood Pressure) 03/2021 - 08/2003
5	Type 2 Diabetes Mellitus (MODY) 03/2021 - 12/2013
4	Coronary Disease (Coronary Heart Disease) 07/2019 - 10/2002
3	Diabetes Mellitus 03/2022 - 10/2008
3	Vascular Diseases (Vascular Disease) 03/2021 - 09/2020
3	Insulin Resistance 09/2008 - 08/2003
2	Peripheral Arterial Disease 01/2021 - 03/2008
2	Stroke (Strokes) 01/2021 - 03/2008
2	Dyslipidemias (Dyslipidemia) 11/2019 - 03/2008
2	Hemorrhage 01/2018 - 04/2015
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016 - 03/2008
2	Heart Failure 04/2009 - 03/2008
2	Obesity 10/2008 - 03/2008
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2022
1	Chronic Renal Insufficiency 03/2022
1	COVID-19 01/2021
1	Acute Coronary Syndrome 01/2021
1	Atrial Fibrillation 02/2020
1	Renal Insufficiency (Renal Failure) 07/2019
1	Albuminuria 01/2018
1	Alcoholism (Alcohol Abuse) 01/2018
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Neoplasms (Cancer) 04/2015
1	Heart Diseases (Heart Disease) 11/2013
1	Hypercholesterolemia 10/2008
1	Abdominal Obesity 01/2006
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2006
1	Atherosclerosis 08/2003
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2003
1	Myocardial Infarction 02/2003

Drug/Important Bio-Agent (IBA)

7	LipidsIBA 03/2022 - 01/2006
5	CholesterolIBA 11/2019 - 10/2008
4	LDL CholesterolIBA 03/2022 - 03/2008
3	PCSK9 InhibitorsIBA 03/2021 - 09/2020
3	Metformin (Glucophage)FDA LinkGeneric 03/2021 - 09/2020
3	DNA Transposable Elements (Element, IS)IBA 03/2021 - 09/2020
3	oxidized low density lipoproteinIBA 01/2021 - 07/2009
3	Antihypertensive Agents (Antihypertensives)IBA 07/2019 - 03/2008
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 08/2006
1	CreatinineIBA 03/2022
1	AlbuminsIBA 03/2022
1	Triglycerides (Triacylglycerol)IBA 05/2021
1	Lipoproteins (Lipoprotein)IBA 03/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	apixabanIBA 02/2020
1	HDL CholesterolIBA 07/2019
1	ProteomeIBA 01/2018
1	Neprilysin (Neutral Endopeptidase)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	nalmefene (Revex)FDA Link 01/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 04/2012
1	prednylidene (Pred)IBA 09/2008
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	LDL Lipoproteins (beta Lipoproteins)IBA 03/2008
1	2,5-dihydroxybenzene-1,4-disulfonic acid-bis(diethylamine) (263E)IBA 08/2006
1	LeptinIBA 08/2003

Therapy/Procedure

3	Secondary Prevention 01/2011 - 10/2002
1	Glycemic Control 03/2022
1	Therapeutics 01/2021
1	Polypharmacy 01/2021
1	Patient Readmission 04/2009
1	Drug Therapy (Chemotherapy) 02/2003